BioLineRx (BLRX) Inventory Average (2023 - 2026)

BioLineRx's Inventory Average history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Inventory Average fell 35.28% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 35.28% YoY), while the FY2025 annual figure was $2.6 million, up 3.83% from the prior year.
• Inventory Average for Q4 2025 stood at $2.2 million, down from $2.5 million in the prior quarter.
• The five-year high for Inventory Average was $3.6 million in Q3 2024, with the low at $1.7 million in Q4 2023.
• The 3-year median for Inventory Average is $3.1 million (2025), against an average of $2.8 million.
• The sharpest annual moves came in 2024 and 2025: Inventory Average jumped 102.39% in 2024, then tumbled 35.28% in 2025.
• BioLineRx's Inventory Average stood at $1.7 million in 2023, then surged by 102.39% to $3.3 million in 2024, then tumbled by 35.28% to $2.2 million in 2025.
• Business Quant data shows BLRX's Inventory Average at $2.2 million in Q4 2025, $2.5 million in Q3 2025, and $3.1 million in Q2 2025.